These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16895480)

  • 21. Distribution of tripeptidyl peptidase I in human tissues under normal and pathological conditions.
    Kida E; Golabek AA; Walus M; Wujek P; Kaczmarski W; Wisniewski KE
    J Neuropathol Exp Neurol; 2001 Mar; 60(3):280-92. PubMed ID: 11245212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
    Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
    Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R208X mutation in CLN2 gene associated with reduced cerebrospinal fluid pterins in a girl with classic late infantile neuronal ceroid lipofuscinosis.
    Barisić N; Logan P; Pikija S; Skarpa D; Blau N
    Croat Med J; 2003 Aug; 44(4):489-93. PubMed ID: 12950156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tripeptidyl peptidases: enzymes that count.
    Tomkinson B
    Trends Biochem Sci; 1999 Sep; 24(9):355-9. PubMed ID: 10470035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH.
    Lin L; Sohar I; Lackland H; Lobel P
    J Biol Chem; 2001 Jan; 276(3):2249-55. PubMed ID: 11054422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exclusion of late infantile neuronal ceroid lipofuscinosis (LINCL) in a fetus by assay of tripeptidyl peptidase I in chorionic villi.
    Young EP; Winchester BG; Peter Logan W; Wheeler RB; Lake BD
    Prenat Diagn; 2000 Apr; 20(4):337-9. PubMed ID: 10740208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maturation of human tripeptidyl-peptidase I in vitro.
    Golabek AA; Wujek P; Walus M; Bieler S; Soto C; Wisniewski KE; Kida E
    J Biol Chem; 2004 Jul; 279(30):31058-67. PubMed ID: 15143070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosaminoglycans modulate activation, activity, and stability of tripeptidyl-peptidase I in vitro and in vivo.
    Golabek AA; Walus M; Wisniewski KE; Kida E
    J Biol Chem; 2005 Mar; 280(9):7550-61. PubMed ID: 15582991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-infantile neuronal ceroid lipofuscinosis (CLN2/Jansky-Bielschowsky type) in Oman.
    Koul R; Al-Futaisi A; Ganesh A; Rangnath Bushnarmuth S
    J Child Neurol; 2007 May; 22(5):555-9. PubMed ID: 17690061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of tripeptidyl-peptidase I provides insight into the molecular basis of late infantile neuronal ceroid lipofuscinosis.
    Pal A; Kraetzner R; Gruene T; Grapp M; Schreiber K; Grønborg M; Urlaub H; Becker S; Asif AR; Gärtner J; Sheldrick GM; Steinfeld R
    J Biol Chem; 2009 Feb; 284(6):3976-84. PubMed ID: 19038966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The substrate range of tripeptidyl-peptidase I.
    Bernardini F; Warburton MJ
    Eur J Paediatr Neurol; 2001; 5 Suppl A():69-72. PubMed ID: 11589011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rat tripeptidyl peptidase I: molecular cloning, functional expression, tissue localization and enzymatic characterization.
    Du PG; Kato S; Li YH; Maeda T; Yamane T; Yamamoto S; Fujiwara M; Yamamoto Y; Nishi K; Ohkubo I
    Biol Chem; 2001 Dec; 382(12):1715-25. PubMed ID: 11843185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prosegment of tripeptidyl peptidase I is a potent, slow-binding inhibitor of its cognate enzyme.
    Golabek AA; Dolzhanskaya N; Walus M; Wisniewski KE; Kida E
    J Biol Chem; 2008 Jun; 283(24):16497-504. PubMed ID: 18411270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-glycosylation is crucial for folding, trafficking, and stability of human tripeptidyl-peptidase I.
    Wujek P; Kida E; Walus M; Wisniewski KE; Golabek AA
    J Biol Chem; 2004 Mar; 279(13):12827-39. PubMed ID: 14702339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland.
    Moore SJ; Buckley DJ; MacMillan A; Marshall HD; Steele L; Ray PN; Nawaz Z; Baskin B; Frecker M; Carr SM; Ives E; Parfrey PS
    Clin Genet; 2008 Sep; 74(3):213-22. PubMed ID: 18684116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased brain lysosomal pepstatin-insensitive proteinase activity in patients with neurodegenerative diseases.
    Junaid MA; Pullarkat RK
    Neurosci Lett; 1999 Apr; 264(1-3):157-60. PubMed ID: 10320038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tripeptidyl peptidase-I is essential for the degradation of sulphated cholecystokinin-8 (CCK-8S) by mouse brain lysosomes.
    Warburton MJ; Bernardini F
    Neurosci Lett; 2002 Oct; 331(2):99-102. PubMed ID: 12361850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific substrate for CLN2 protease/tripeptidyl-peptidase I assay.
    Junaid MA; Brooks SS; Pullarkat RK
    Eur J Paediatr Neurol; 2001; 5 Suppl A():63-8. PubMed ID: 11589010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases.
    Wlodawer A; Durell SR; Li M; Oyama H; Oda K; Dunn BM
    BMC Struct Biol; 2003 Nov; 3():8. PubMed ID: 14609438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations.
    Steinfeld R; Heim P; von Gregory H; Meyer K; Ullrich K; Goebel HH; Kohlschütter A
    Am J Med Genet; 2002 Nov; 112(4):347-54. PubMed ID: 12376936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.